Production (Stage)
ProKidney Corp.
PROK
$0.9776
$0.190624.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -76.30% | -273.23% | -63.06% | -37.16% | 1.79% |
| Total Depreciation and Amortization | 45.19% | 37.35% | 47.86% | 45.98% | 32.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.85% | 10.96% | 36.27% | -22.16% | -38.97% |
| Change in Net Operating Assets | 119.16% | 349.55% | -104.57% | -180.66% | -137.49% |
| Cash from Operations | 14.59% | 4.78% | -22.98% | -156.72% | -33.29% |
| Capital Expenditure | -18.23% | -1,522.71% | 91.40% | 82.81% | 2.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -50.43% | 143.06% | -18,114.02% | 408.96% | 130.98% |
| Cash from Investing | -51.56% | 115.73% | -187.71% | 317.21% | 130.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 7.69% | -7.69% | -7.69% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.69% | 101.29% | 34,376.92% | 1,075,807.69% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -105.54% | 93.14% | -104.01% | 563.35% | 110.86% |